NEWPORT BEACH, Calif. – Scientists at Abbott subsidiary Ibis Biosciences have developed an assay to detect and genotype Borrelia burgdorferi, the bacterium responsible for causing Lyme disease in humans, using Abbott's Plex-ID microbial identification system.

The assay, which is currently for research use only, has sensitivity and specificity comparable to that of the current gold standard diagnostic method, a two-tiered serology-based test that can take as long as a month to provide a definitive result.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.